Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 13/20 | 0.69 |
| ▸ | ERBB2 | P04626 | 7/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 1/20 | 0.69 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | BRAF | P15056 | 2/20 | 0.49 |
| ▸ | SYK | P43405 | 2/20 | 0.46 |
| ▸ | ERBB4 | Q15303 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | BTK | Q06187 | 1/20 | 0.44 |
| ▸ | BCL6 | P41182 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3473824 | 0.90 | EGFR (0.76) | EGFRERBB2HPGDHTTCSNK2A1 | |
| SCHEMBL6989676 | 0.90 | EGFR (0.76) | EGFRERBB2HPGDHTTCSNK2A1 | |
| SCHEMBL8318694 | 0.88 | EGFR (0.73) | EGFRERBB2HPGDHTTCSNK2A1 | |
| SCHEMBL8318688 | 0.88 | EGFR (0.73) | EGFRERBB2HPGDHTTCSNK2A1 | |
| SCHEMBL7584754 | 0.88 | EGFR (0.66) | EGFRERBB2HPGDHTTCSNK2A1 | |
| SCHEMBL7584741 | 0.88 | EGFR (0.66) | EGFRERBB2HPGDHTTCSNK2A1 | |
| SCHEMBL8314263 | 0.88 | EGFR (0.84) | EGFRERBB2HPGDHTTCSNK2A1 | |
| SCHEMBL8319512 | 0.88 | EGFR (0.70) | EGFRERBB2HPGDHTTCSNK2A1 | |
| SCHEMBL8319506 | 0.88 | EGFR (0.70) | EGFRERBB2HPGDHTTCSNK2A1 | |
| SCHEMBL6995784 | 0.88 | EGFR (0.70) | EGFRERBB2HPGDHTTCSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888351-B1 | PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION | THOMAE GMBH DR K (DE) | 2003-10-15 | — | — | EP | disclosed |
| EP-0779888-B1 | PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM | BOEHRINGER INGELHEIM PHARMA (DE) | 1999-04-28 | — | — | EP | disclosed |